Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors

Core Insights - Invivyd, Inc. has appointed Dr. Paul B. Bolno to its Board of Directors and Compensation Committee, bringing extensive experience from his role as President and CEO of Wave Life Sciences [1][2] Company Overview - Invivyd, Inc. is a biopharmaceutical company focused on delivering protection against serious viral infectious diseases, starting with SARS-CoV-2 [3] - The company utilizes a proprietary integrated technology platform designed to assess, monitor, develop, and adapt to create best-in-class antibodies [3] - In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody in its pipeline [3] Leadership Appointment - Dr. Bolno's appointment is seen as timely as Invivyd transitions towards a focus on preventing major viral infectious diseases [2] - His experience in rapid pipeline development at Wave Life Sciences is expected to benefit Invivyd's efforts to advance its own pipeline [2] - Dr. Bolno also serves on the Board of Directors of ExpressionEdits and chairs the Scientific Advisory Group for the Nucleic Acid Therapy Accelerator [2] Strategic Focus - The company aims to keep large populations healthy by addressing viral infectious diseases, including acute COVID and potentially Long COVID [2][3] - Dr. Bolno expressed a commitment to scientific excellence and innovation in the prevention and treatment of viral diseases [3]